Prof Richard Houlston: key facts
- Kind of voice
- Academic
- Role
- head of the division of genetics and epidemiology at the Institute of Cancer Research, London
- Quoted on
- Cancer, Hospital discharge / bed-blocking
- Tracked press citations
- 2
- Most recently quoted
- 10 Sept 2026
- First quoted
- 27 Aug 2026
“The press release around the NHS-Galleri trial highlights the familiar misconception that a favourable trend is almost as persuasive as a statistically robust result.”
What Prof Richard Houlston has said
“This is the largest randomised trial so far to evaluate a multi-cancer early detection blood test. However, the researchers have presented their findings far more positively than the overall results justify.”
head of the division of genetics and epidemiology at the Institute of Cancer Research, London · Hospital discharge / bed-blocking · 27 Aug 2026 · Trial of multi-cancer blood test among 142,000 NHS patients fails to meet main aim ↗
Where Prof Richard Houlston has been quoted
- Blood test to detect 50 types of cancer fails to meet key outcome in NHS trialpulsetoday.co.uk · 10 Sept 2026
- Trial of multi-cancer blood test among 142,000 NHS patients fails to meet main aimtheguardian.com · 27 Aug 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.